Articles about silverback

Silverback Therapeutics prices IPO at $21/share, will raise $241M in 4th Wash. state IPO of 2020

Silverback Therapeutics will raise $241.5 million as the Seattle biotech company goes public Friday. Silverback priced its IPO on Thursday… Read More

Seattle biotech firm Silverback Therapeutics sets terms for IPO, looks to raise up to $151M

Silverback Therapeutics plans to raise up to $151.8 million in its initial public offering, the Seattle-based company said Monday in… Read More

Seattle biotech startup Silverback Therapeutics raises $78.5M

Seattle biotech startup Silverback Therapeutics raised a $78.5 million investment round to support development of its therapies for cancer, fibrosis,… Read More